MedPath

Effects of Packed Red Blood Cell Storage Duration on Pediatric Living Donor Liver Transplantation

Not Applicable
Conditions
Transfusion Related Complication
Interventions
Procedure: RBC transfustion
Registration Number
NCT04413721
Lead Sponsor
RenJi Hospital
Brief Summary

The patients assigned to either short-storage leukoreduced RBCs group (stored for ≤ 14 days) or longer-term storage leukoreduced RBCs group(stored for ≥21 days).When the hemoglobin concentration fell below 7.0 g per deciliter, PRBC were given to maintain the hemoglobin concentrations in the range of 7.0 to 10.0/dL. The primary outcome : Death from all causes in1-year after randomization. Secondary outcomes included: Intraoperative blood transfusion, Postoperative blood transfusion, Postoperative inflammatory reaction, Mechanical ventilation time in the intensive care unit, Lengths of stay in the intensive care unit and the hospital were also recorded.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
360
Inclusion Criteria
  • Our study included pediatric patients (6 months< the moon's age <36 months) who will receive standard living-donor liver transplantation (LDLT) in Renji Hospital.
Exclusion Criteria
  • The exclu¬sion criteria of the study were a congenital sufferer from heart, lung, kidney, nervous system or blood disease,active Lung infection,a history of liver transplantation,Multivisceral transplantation , refused to participate the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Short-term storage RBCs (stored for ≤ 14 days)RBC transfustionpatients in this group were transfused with short-term storage RBCs (stored for ≤ 14 days).
Longer-term storage RBCs (stored for ≥21 days)RBC transfustionpatients in this group were transfused with longer-term storage RBCs (stored for ≥21 days).
Primary Outcome Measures
NameTimeMethod
Mortality in in1-year after randomization1-year after randomization.

Death from all causes in1-year after randomization.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath